Integer Holdings: Medical Device CDMO Announces Board Leadership Transition

By Amit Chowdhry • Yesterday at 2:41 PM

Integer Holdings announced that Pamela G. Bailey will not stand for re-election as independent Chair of the Board at the company’s 2026 Annual Meeting of Stockholders scheduled for May 20, 2026. Following the meeting, the Board intends to appoint current director Donald J. Spence as independent Chair.

Bailey’s departure marks a planned leadership transition at the board level as the company continues executing its long-term value creation strategy alongside CEO Payman Khales and the executive team.

Spence, who has served on the Board since 2016, currently chairs the Compensation and Organization Committee and is a member of the Corporate Governance and Nominating and Technology Strategy Committees. He previously served as President and Chief Executive Officer of Ebb Therapeutics and earlier held senior leadership roles at Lake Region Medical, Philips Respironics, Philips Home Healthcare Solutions, GKN Sinter Metals, and the BOC Group.

Integer Holdings Corporation is a global medical device contract development and manufacturing organization serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets.

KEY QUOTES:

“It has been a privilege to serve on the Integer Board and to play my part in the Company’s growth and strategic success. I am confident that under Don’s leadership, the Board will continue to work closely and effectively with CEO Payman Khales and the executive team to support the advancement of Integer’s value creation strategy.”

Pamela G. Bailey, Independent Chair of the Board, Integer Holdings Corporation

“On behalf of the Board of Directors, I wish to thank Pam for her many years of devoted service to Integer, including her leadership as Chair of the Board. As we move forward, I am honored to have the opportunity to serve as Chair. I strongly believe that Integer is well positioned, with a clear strategy and experienced leadership team to deliver long-term value to stockholders.”

Donald J. Spence, Director and Incoming Independent Chair of the Board, Integer Holdings Corporation